Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines

por Lamtha, Thomanai, Tabtimmai, Lueacha, Songtawee, Napat, Tansakul, Natthasit, Choowongkomon, Kiattawee
Publicado 2022

A novel nanobody as therapeutics target for EGFR-positive colorectal cancer therapy: exploring the effects of the nanobody on SW480 cells using proteomics approach

por Lamtha, Thomanai, Krobthong, Sucheewin, Yingchutrakul, Yodying, Samutrtai, Pawitrabhorn, Gerner, Christopher, Tabtimmai, Lueacha, Choowongkomon, Kiattawee
Publicado 2022

Biochemical and structural comparisons of non-nucleoside reverse transcriptase inhibitors against feline and human immunodeficiency viruses

por Rattanabunyong, Siriluk, Choengpanya, Khuanjarat, Suwattanasophon, Chonticha, Kiriwan, Duangnapa, Wolschann, Peter, Lamtha, Thomanai, Shaikh, Abdul Rajjak, Rattanasrisomporn, Jatuporn, Choowongkomon, Kiattawee
Publicado 2023

Identification of the Brucea javanica Constituent Brusatol as a EGFR-Tyrosine Kinase Inhibitor in a Cell-Free Assay

por Suwattanasophon, Chonticha, Mistlberger-Reiner, Agnes, Alberdi-Cedeño, Jon, Pignitter, Marc, Somoza, Veronika, König, Jürgen, Lamtha, Thomanai, Wanaragthai, Panatda, Kiriwan, Duangnapa, Choowongkomon, Kiattawee
Publicado 2023